Icalcaprant not checked

AbbVie · ABBV-1354 · CVL-354

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
2 active
7 in total

What this is

How it works
How it works isn't classified yet
Tested for
Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder
Main trialPhase 2
“Major depressive disorder (MDD; depression) is a mood disorder that causes a continued feeling of sadness and loss of interest. It is a common and serious illness that can cause both emotional and physical symptoms such as feelings of sadness, irritability, not being able to focus on activities, tiredness, changes in eating habits, and aches and pains. This study will assess the changes in disease activity and adverse events of oral Icalcaprant in adult participants with major depressive disorder who are currently experiencing a major depressive episode (MDE). Icalcaprant is an…”In the company’s words, NCT07276997 on ClinicalTrials.gov
Other names
ABBV-1354 · CVL-354

Other drugs for Major Depressive Disorder

All 36 drugs for Major Depressive Disorder

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials7

TrialPhaseCompletesWhat it tests
Phase 2Recruiting Sep 2027 A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Phase 2Recruiting Nov 2027 A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Phase 1Completed 23 Jan 2023 A Single and Multiple Ascending Dose Trial of CVL-354 in Healthy Participants
Phase 1Completed 24 Jul 2024 Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing
Phase 1Completed 13 Jan 2025 A Study to Assess Change in How Oral Icalcaprant With Itraconazole Moves Through the Body in Healthy Adult Participants
Phase 1Completed 17 Jan 2025 A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Japanese and Han Chinese Participants
Phase 1Completed 9 Dec 2025 A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Icalcaprant

Following is part of Solo: you see every change to Icalcaprant the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in